Your browser doesn't support javascript.
loading
Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.
Boyle, Stephen; Tobin, Joshua W D; Perram, Jacinta; Hamad, Nada; Gullapalli, Veena; Barraclough, Allison; Singaraveloo, Lydia; Han, Min-Hi; Blennerhassett, Richard; Nelson, Niles; Johnston, Anna M; Talaulikar, Dipti; Karpe, Krishna; Bhattacharyya, Abir; Cheah, Chan Yoon; Subramoniapillai, Elango; Bokhari, Waqas; Lee, Cindy; Hawkes, Eliza A; Jabbour, Andrew; Strasser, Simone I; Chadban, Steven J; Brown, Christina; Mollee, Peter; Hapgood, Greg.
Afiliação
  • Boyle S; Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Tobin JWD; University of Queensland, Brisbane, Queensland, Australia.
  • Perram J; University of Queensland, Brisbane, Queensland, Australia.
  • Hamad N; Department of Haematology, Gold Coast University Hospital, Gold Coast, Queensland, Australia.
  • Gullapalli V; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Barraclough A; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • Singaraveloo L; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Han MH; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • Blennerhassett R; Department of Haematology and Olivia Newton John Cancer Research Institute, The Austin Hospital, Melbourne, Victoria, Australia.
  • Nelson N; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Johnston AM; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Talaulikar D; Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Karpe K; University of Sydney, Sydney, New South Wales, Australia.
  • Bhattacharyya A; Royal Hobart Hospital, Hobart, Tasmania, Australia.
  • Cheah CY; Royal Hobart Hospital, Hobart, Tasmania, Australia.
  • Subramoniapillai E; University of Tasmania, Hobart, Tasmania, Australia.
  • Bokhari W; Department of Haematology, Canberra Hospital, Canberra, Australian Capital Territory, Australia.
  • Lee C; Australian National University, Canberra, Australian Capital Territory, Australia.
  • Hawkes EA; Department of Renal Medicine, Canberra Hospital, Canberra, Australian Capital Territory, Australia.
  • Jabbour A; Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Strasser SI; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Chadban SJ; University of Western Australia, Crawley, Western Australia, Australia.
  • Brown C; Royal Brisbane Hospital, Brisbane, Queensland, Australia.
  • Mollee P; Royal Brisbane Hospital, Brisbane, Queensland, Australia.
  • Hapgood G; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Hemasphere ; 5(11): e648, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34651103
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Hemasphere Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Hemasphere Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália